Back to Search

MARTIN GORDON

Addiction (Substance Use Disorder) Counselor

NPI: 1326133323Individual

Specialties, Licenses & Credentials

Addiction (Substance Use Disorder) CounselorPrimary

Counselor — Addiction (Substance Use Disorder)

Code: 101YA0400X

11815(WI)

Clinical Trials (1)

1
Linked Trials
0
Recruiting
1
With Results

Magnetic Resonance Spectroscopy Study of Memantine in Alzheimer's Disease

NCT00551161COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR

Research & Publications (13)

Treatment monitoring and response prediction with proton MR spectroscopy in AD.
PMID 16894124·Neurology·2006
8-other
Cognitive control and semantics in schizophrenia: an integrated approach.
PMID 16199848·Am J Psychiatry·2005
8-other
Efficacy of proton magnetic resonance spectroscopy in neurological diagnosis and neurotherapeutic decision making.
PMID 15897945·NeuroRx·2005
6-review
Conversion from mild cognitive impairment to probable Alzheimer's disease predicted by brain magnetic resonance spectroscopy.
PMID 15800137·Am J Psychiatry·2005
4-observational
Deaths: leading causes for 2002.
PMID 15786629·Natl Vital Stat Rep·2005
8-other
Deaths: preliminary data for 2003.
PMID 15779680·Natl Vital Stat Rep·2005
8-other
In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease.
PMID 15588758·Prog Neuropsychopharmacol Biol Psychiatry·2004
4-observational
The relationship between cognitive impairment and in vivo metabolite ratios in patients with clinical Alzheimer's disease and vascular dementia: a proton magnetic resonance spectroscopy study.
PMID 12879326·Neuroradiology·2003
8-other
Fine-needle, negative-pressure lumbar puncture: a safe technique for collecting CSF.
PMID 12499507·Neurology·2002
3-trial
Neuroprotection by memantine against neurodegeneration induced by beta-amyloid(1-40).
PMID 12468047·Brain Res·2002
7-preclinical
Longitudinal quantitative proton magnetic resonance spectroscopy of the hippocampus in Alzheimer's disease.
PMID 12244089·Brain·2002
4-observational
Brain metabolite concentration and dementia severity in Alzheimer's disease: a (1)H MRS study.
PMID 11524470·Neurology·2001
8-other
Longitudinal decline of the neuronal marker N-acetyl aspartate in Alzheimer's disease.
PMID 10905250·Lancet·2000
8-other

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
37390 N BRADUM RD
BAYFIELD, WI 54814

Location

Practice Location

37390 N BRADUM RD, BAYFIELD, WI
(715) 779-3741

Quick Facts

NPI
1326133323
Entity Type
Individual
Gender
Male
Medicare
Not confirmed
Specialties
1
Locations
1
Clinical Trials
1
Publications
13

Are you this provider?

Claim Your Profile